Gut-restricted farnesoid X receptor agonist fexaramine improves abnormal metabolic and reproductive phenotypes in polycystic ovary syndrome model mice

Reproductive and Developmental Medicine · Published 2026-03-26 · DOI 10.1097/rd9.0000000000000162

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1097/rd9.0000000000000162

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• The quality control standards for diagnosis and treatment of polycystic ovary syndrome in Obstetrics and Gynecology Hospital of Fudan University · Reproductive and Developmental Medicine · 2025 · Same journal
• Effect of Jinfeng Pill on ovarian function of Tripterygium wilfordii polyglycoside tablets induced poor ovarian response rats · Reproductive and Developmental Medicine · 2024 · Same journal
• Developing a mouse endometriosis model using stored chocolate cyst slurry: an experimental study · Reproductive and Developmental Medicine · 2025 · Same journal
• Updates on in vitro maturation technology in human immature oocytes for clinical application · Reproductive and Developmental Medicine · 2025 · Same journal
• Exploring the Feasibility of Using Self-Sampling for HPV E6/E7 mRNA Detection in Cervical Cancer Screening Programs · Reproductive and Developmental Medicine · 2026 · Same journal
• Effect of selenium on reproductive function and oxidative stress in male rats with cisplatin-induced testicular damage · Reproductive and Developmental Medicine · 2025 · Same journal
• Understanding lichen sclerosus: pathogenesis and treatment · Reproductive and Developmental Medicine · 2025 · Same journal
• Vaginal repair as salvage therapy benefits women with cesarean scar defects after failed repair surgery: a retrospective cohort study · Reproductive and Developmental Medicine · 2025 · Same journal
• Causal effects linking polycystic ovary syndrome and testosterone levels to obstetric outcomes: a two-sample Mendelian randomization study · Reproductive and Developmental Medicine · 2026 · Same journal
• The impact of body mass index on the outcomes of in vitro fertilization in patients with polycystic ovary syndrome · Reproductive and Developmental Medicine · 2025 · Same journal